Kidney transplantation – be aware of TCC
Plasma TCC (sC5b-9) is associated with both patient and kidney long-time survival.
Nephrologists from aHUS and OUS Rikshospitalet have together with complementologists from NCRG recently presented data in Front Immunol showing data in 900 patients over a 10-year period that increased plasma TCC levels obtained in a stable period at 10 weeks after transplantation was associated with patient survival, graft survival and with death-censored graft loss.
Plasma TCC has again strengthened its position as an important marker in disease pathophysiology, adding another possible indication for complement therapeutic in the future.
Bartlomiej J. Witczak and Søren E. Pieschke were 1st and 2nd authors, and Anders Åsberg and Tom E. Mollnes shared the last authorship.
Here is the link to all authors and the paper – released by Frontiers and will soon be available on PuMed:
Similar News
Søren E. Pischke received a prestigious honorary award
Award and honour to Søren E. Pischke. The NCRG group member, anaesthesiologist, and critical care expert, Dr. Søren Pischke,...
Read more6th NCRG Symposium at Kjerringøy
19 members of the NCRG joined the 6th Norwegian Complement Symposium at Kjerringøy. Kjerringøy is an old traditional trading place ...
Read moreViktoriia Chaban defended her PhD
MD Viktoriia Chaban at Institute of Clinical Medicine defended her thesis “Innate immune responses to sterile inflammation after acute brain...
Read more